SY-001 is under clinical development by CellOrigin Technology (Hangzhou) and currently in Phase I for Solid Tumor.
Joe Panetta to step down as Biocom California CEO
Joe Panetta, who has led the trade group Biocom California for 25 years, is slated to step down as president and CEO at the end